Burden, Mortality and Supply Costs in Intensive Care Unit Patients
Recruiting
Observational Study
Burden, Dependency
Mortality
End-of-life Care
Intensive Care Unit
Critically Ill Patient
Frailty
Multiple Organ Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 700 (estimated)
- Sponsor
- University of Ulm · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study systematically observes in a pragmatic trail under real world conditions the association between strategies of therapy (maximal therapy, withhold, withdraw) and treatment success in three endpoint related initial risk groups (high, intermediate, low risk) regarding three endpoints (burden, mortality and supply costs).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients dying on the ICU and all patients staying for at least 72 hours on the ICU
Exclusion Criteria:
* No
Contacts